Erica Ollmann Saphire's $49 million project, America’s SHIELD, aims to develop vaccines for herpesviruses, addressing viral latency and multiple infection mechanisms. The initiative involves a consortium of researchers to tackle the complexity of herpesviruses, focusing on molecular structures, viral genomes, and immune signatures, with potential to significantly impact public health.